Fig. 1 · Structure
Documents & Downloads
trans-Trimethoxyresveratrol
Resveratrol Derivative
Trans-Trimethoxyresveratrol is a natural derivative of Resveratrol with enhanced anticancer properties. It demonstrates significant potency in inhibiting cancer cell proliferation, inducing cell cycle arrest, decreasing metastasis, and promoting apoptosis. This compound disrupts microtubule assembly and triggers tubulin depolymerization, while also exerting anti-angiogenic effects via VEGFR2 modulation. Trans-Trimethoxyresveratrol is suitable for investigations into anti-angiogenic therapies and cancer research, particularly in non-small cell lung cancer and osteosarcoma.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 22255-22-7 |
| Applications | Resveratrol Derivative |
| Formula | C17H18O3 |
| Molecular Weight | 270.32 |
| Synonyms | trans-trismethoxy Resveratrol; (E)-Resveratrol trimethyl ether; trans-3,5,4'-Trimethoxystilbene |
| SMILES | COC1=CC=C(/C=C/C2=CC(OC)=CC(OC)=C2)C=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.